Another FDA-approved IMS system is the CliniMACS CD34 Reagent System by Miltenyi Biotec utilizing the anti-CD34 for clinical allogeneic stem cell transplantation in patients with acute myeloid leukemia [137]. Here, CD34 is linked to acute myeloid leukemia.